Edition:
United Kingdom

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

59.36EUR
16 Aug 2019
Change (% chg)

€0.80 (+1.37%)
Prev Close
€58.56
Open
€58.44
Day's High
€59.52
Day's Low
€58.14
Volume
1,024,357
Avg. Vol
870,135
52-wk High
€91.74
52-wk Low
€55.44

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)

Overall

Beta: 0.37
Market Cap(Mil.): €25,665.52
Shares Outstanding(Mil.): 307.96
Dividend: 0.96
Yield (%): 1.15

Financials

  FMEG.DE Industry Sector
P/E (TTM): 20.57 27.97 32.67
EPS (TTM): 4.05 -- --
ROI: 8.40 6.82 14.48
ROE: 13.39 10.86 15.78

Bridgepoint tests appetite for $2.2 bln dialysis clinic firm Diaverum - sources

FRANKFURT/LONDON, July 30 European buyout firm Bridgepoint is exploring a sale or stock market listing of its dialysis clinic operator Diaverum as part of a long-anticipated exit plan that could fetch up to 2 billion euros ($2.23 billion), sources close to the matter told Reuters.

30 Jul 2019

Fresenius slides as weakness in dialysis unit offsets improved outlook

Shares in German healthcare group Fresenius slid on Tuesday after its dialysis unit FMC reported smaller than expected cost savings and said full-year earnings growth would likely come in at the lower end of guidance.

30 Jul 2019

UPDATE 4-Fresenius slides as weakness in dialysis unit offsets improved outlook

* Fresenius expects FY 4%-7% revenue growth at constant currency

30 Jul 2019

Fresenius Medical Care confirms 2019 targets

German dialysis specialist Fresenius Medical Care reported on Tuesday a 3% rise in its second-quarter revenue, citing healthy growth in its U.S. dialysis business.

30 Jul 2019

Fresenius Medical Care confirms 2019 targets

July 30 German dialysis specialist Fresenius Medical Care reported on Tuesday a 3% rise in its second-quarter revenue, citing healthy growth in its U.S. dialysis business.

30 Jul 2019

Shareholders reproach Germany's Fresenius Medical Care after foreign bribery case

* ISS recommends no confidence vote on U.S. bribery settlement

16 May 2019

UPDATE 2-Fresenius makes solid start to year after turbulent 2018

* Confirms full-year guidance (Adds analysts, shares, details)

02 May 2019

Fresenius Medical Care to pay $231 million to resolve criminal, civil foreign bribery charges

Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice Department said on Friday.

29 Mar 2019

UPDATE 2-Fresenius Medical Care to pay $231 mln to resolve criminal, civil foreign bribery charges

March 29 Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice Department said on Friday.

29 Mar 2019

FMC wraps up $2 bln acquisition of NxStage

BERLIN, Feb 22 Germany's Fresenius Medical Care (FMC) wrapped up its $2 billion acquisition of U.S. home dialysis maker NxStage Medical on Friday, according to a U.S. Securities and Exchange Commission filing.

22 Feb 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates